Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic	Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder	Recruiting	Phase 4	2026-10-09		NCT07176351

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Braeburn Pharmaceuticals	1
Yale University	458

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Yale School of Medicine	New Haven	United States	17

Clinical trials